← back to search

Xiaoqiang Li

Air Force Engineering University · CN
Area of research
Radiation · Pulmonary and Respiratory Medicine
Research interest
Research interests include Advanced Radiotherapy Techniques, Radiation Therapy and Dosimetry, Polysaccharides and Plant Cell Walls, and Ion Channels and Receptors.
h-index
47
citations
6,778
works
294
NIH funding
primary concept
email

Recent publications

Decoding the healing secrets of Gegenqinlian decoction: A promising approach to radiation-induced intestinal injury
Journal of Ethnopharmacology 2026cited by 3position: contributordoi
Unraveling the mechanism of Lianqiaobaidu powder in viral myocarditis: Complementary actions within cardiac cell types
Journal of Pharmaceutical Analysis 2026cited by 0position: contributordoi
HINT1 aggravates aortic aneurysm by targeting ITGA6/FAK axis in vascular smooth muscle cells
Journal of Clinical Investigation 2025cited by 9position: middledoi
Transient receptor potential channels in viral infectious diseases: Biological characteristics and regulatory mechanisms.
2025cited by 2position: contributordoi
Inhibition of FAK promotes pancreatic cancer immunotherapy by mediating CXCL10 secretion to enhance CD8<sup>+</sup> T cell infiltration.
2025cited by 1position: contributordoi
RETRACTED: NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score
Heliyon 2024cited by 60position: middledoi
SLC44A2 regulates vascular smooth muscle cell phenotypic switching and aortic aneurysm
Journal of Clinical Investigation 2024cited by 39position: middledoi
α-Glucan derivatives as selective blockers of aldolase A: Computer-aided structure optimization and the effects on HCC.
2024cited by 5position: contributordoi
DESIGN A TIME-EFFICIENT PROTON ARC TREATMENT SYSTEM CONTROLLER
International Journal of Particle Therapy 2024cited by 0position: middledoi
Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation.
2023cited by 19position: contributordoi
Piperlonguminine attenuates renal fibrosis by inhibiting TRPC6.
2023cited by 11position: contributordoi
Canonical transient receptor potential channel 1 aggravates myocardial ischemia-and-reperfusion injury by upregulating reactive oxygen species.
2023cited by 6position: contributordoi
The synthesis and effects of a novel TRPC6 inhibitor, BP3112, on hepatocellular carcinoma.
2023cited by 5position: contributordoi
Screening of rosmarinic acid from <i>Salvia miltiorrhizae</i> acting on the novel target TRPC1 based on the 'homology modelling-virtual screening-molecular docking-affinity assay-activity evaluation' method.
2023cited by 1position: contributordoi
Corrigendum to "Apple polysaccharide prevents from colitis-associated carcinogenesis through regulating macrophage polarization" [Int. J. Biol. Macromol. 161C (2020) 704-711].
2023cited by 0position: contributordoi
The structures of two polysaccharides from Angelica sinensis and their effects on hepatic insulin resistance through blocking RAGE.
2022cited by 50position: contributordoi
TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca<sup>2+</sup> leakage.
2022cited by 31position: contributordoi
Old targets, new strategy: Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside prevents endothelial ferroptosis and alleviates intestinal ischemia-reperfusion injury through HO-1 and MAO-B inhibition.
2022cited by 30position: contributordoi
Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation
Journal of Ethnopharmacology 2022cited by 26position: lastdoi
TRPC1 contributes to endotoxemia-induced myocardial dysfunction via mediating myocardial apoptosis and autophagy.
2022cited by 21position: contributordoi
Complement C5 is a novel biomarker for liver metastasis of colorectal cancer
Journal of Gastrointestinal Oncology 2022cited by 10position: middledoi
Case Report: Stroke Chameleon: Acute Large Vessel Occlusion in the Posterior Circulation With Paroxysmal Sympathetic Hyperactivity as the First Manifestation
Frontiers in Neuroscience 2022cited by 4position: middledoi
Bolbostemma paniculatum (Maxim.) Franquet extract suppresses the development of colorectal cancer through downregulation of PI3K/Akt pathway.
2022cited by 3position: contributordoi
TRPC1 promotes the genesis and progression of colorectal cancer via activating CaM-mediated PI3K/AKT signaling axis.
2021cited by 27position: contributordoi
Structural characteristics of a hypoglycemic polysaccharide from Fructus Corni.
2021cited by 25position: contributordoi
Structures and anti-melanoma activities of two polysaccharides from Angelica sinensis (Oliv.) Diels.
2021cited by 20position: contributordoi
Canonical transient receptor potential channels and their modulators: biology, pharmacology and therapeutic potentials.
2021cited by 19position: contributordoi
Ligustroflavone ameliorates CCl<sub>4</sub>-induced liver fibrosis through down-regulating the TGF-β/Smad signaling pathway.
2021cited by 18position: contributordoi
The antitumor role of a newly discovered α-d-glucan from Holotrichia diomphalia Bates as a selective blocker of aldolase A.
2021cited by 14position: contributordoi
Bolbostemma paniculatum (Maxim.) Franquet extract suppresses the development of colorectal cancer through downregulation of PI3K/Akt pathway
Journal of Ethnopharmacology 2021cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 11 papers (2021–2026)Wei Cao · Elsevier, Inc.4 papers (2021–2026)Liansheng Wang · Sun Yat-sen University2 papers (2024–2025)Xiaolong Du · Shenyang Ligong University2 papers (2024–2025)Shanshan Luo · Technical University of Munich2 papers (2024–2025)Bo Yu · Fudan University2 papers (2024–2025)Zhi‐Ren Zhang · Harbin Medical University2 papers (2024–2025)Yi Han · Harbin Medical University2 papers (2024–2025)Guang-Yuan Ma · Northwest A&F University2 papers (2021–2023)Zhi‐Jian Han · Nanjing Medical University2 papers (2024–2025)Yong Ji · Nanjing University of Chinese Medicine2 papers (2024–2025)Feng Chen · Nanchang University2 papers (2024–2025)Liping Xie · Nanjing University of Chinese Medicine2 papers (2024–2025)Guofeng Li · Guangdong Medical College1 papers (2022–2022)Hong Wang · University of California, Santa Barbara1 papers (2024–2024)Yaling Han · Army Medical University1 papers (2025–2025)Hao Zhang · Jiangnan University1 papers (2019–2019)Chenglong Li · University of Florida1 papers (2015–2015)Yuwei Wang · Zhejiang University1 papers (2021–2021)Jun Yan · Guangzhou University of Chinese Medicine1 papers (2024–2024)